Research.Patient.info

Rejection; Transplant, Liver research hub

2 indexed studies · 1 currently recruiting

active not recruitingPHASE1, PHASE2
Safety and Clinical Activity of QEL-001 in A2-mismatch Liver Transplant Patients
This study looks into a new treatment called QEL-001 for people who have had a liver transplant. The aim is to see if QEL-001, made from the patient's own cells, can help prevent the body from rejecting the new liver, especially when usual anti-rejection medicines are reduced or stopped.
Belgium · Spain · United Kingdom
recruiting
Prospective Study of White Blood Cells
This study looks at white blood cells from healthy volunteers to help create new treatments for serious conditions like autoimmune diseases and organ transplant rejection. By understanding these cells better, scientists hope to develop new medicines that can regulate the body's immune system.
United Kingdom